244 related articles for article (PubMed ID: 38481661)
1. Anti-cancer management of head and neck cancers and oral microbiome-what can we clinically obtain?
Makarewicz J; Kaźmierczak-Siedlecka K; Sobocki BK; Dobrucki IT; Kalinowski L; Stachowska E
Front Cell Infect Microbiol; 2024; 14():1329057. PubMed ID: 38481661
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers.
Deng Z; Uehara T; Maeda H; Hasegawa M; Matayoshi S; Kiyuna A; Agena S; Pan X; Zhang C; Yamashita Y; Xie M; Suzuki M
PLoS One; 2014; 9(11):e113702. PubMed ID: 25405488
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Human Papillomavirus and Co-Infection with Epstein-Barr Virus in Oral and Oropharyngeal Squamous Cell Carcinomas.
Makvandi M; Jalilian S; Faghihloo E; Khanizadeh S; Ramezani A; Bagheri S; Mirzaei H
Asian Pac J Cancer Prev; 2022 Nov; 23(11):3931-3937. PubMed ID: 36444607
[TBL] [Abstract][Full Text] [Related]
4. Precision medicine in head and neck cancer.
Kaidar-Person O; Gil Z; Billan S
Drug Resist Updat; 2018 Sep; 40():13-16. PubMed ID: 30466712
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy in Head and Neck Cancer: Where Do We Stand?
Vallianou NG; Evangelopoulos A; Kounatidis D; Panagopoulos F; Geladari E; Karampela I; Stratigou T; Dalamaga M
Curr Oncol Rep; 2023 Aug; 25(8):897-912. PubMed ID: 37213060
[TBL] [Abstract][Full Text] [Related]
6. Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis.
Jiang R; Ekshyyan O; Moore-Medlin T; Rong X; Nathan S; Gu X; Abreo F; Rosenthal EL; Shi M; Guidry JT; Scott RS; Hutt-Fletcher LM; Nathan CA
J Oral Pathol Med; 2015 Jan; 44(1):28-36. PubMed ID: 25040496
[TBL] [Abstract][Full Text] [Related]
7. Assessing the burden of HPV-related head and neck cancers in mainland China: protocol of a nationwide, multisite, cross-sectional study.
Wang W; Song C; Su Z; Kothari S; Chen YT; Liu Y; Wu SY; Panchal R; Morais E; Zhang SK; Yin J; Qiao YL; Roberts C
BMJ Open; 2023 Nov; 13(11):e073277. PubMed ID: 37968007
[TBL] [Abstract][Full Text] [Related]
8. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
[TBL] [Abstract][Full Text] [Related]
9. Metastatic disease in head & neck oncology.
Pisani P; Airoldi M; Allais A; Aluffi Valletti P; Battista M; Benazzo M; Briatore R; Cacciola S; Cocuzza S; Colombo A; Conti B; Costanzo A; Della Vecchia L; Denaro N; Fantozzi C; Galizia D; Garzaro M; Genta I; Iasi GA; Krengli M; Landolfo V; Lanza GV; Magnano M; Mancuso M; Maroldi R; Masini L; Merlano MC; Piemonte M; Pisani S; Prina-Mello A; Prioglio L; Rugiu MG; Scasso F; Serra A; Valente G; Zannetti M; Zigliani A
Acta Otorhinolaryngol Ital; 2020 Apr; 40(SUPPL. 1):S1-S86. PubMed ID: 32469009
[TBL] [Abstract][Full Text] [Related]
10. Viral and Clinical Oncology of Head and Neck Cancers.
Goon P; Schürmann M; Oppel F; Shao S; Schleyer S; Pfeiffer CJ; Todt I; Brasch F; Scholtz LU; Göerner M; Sudhoff H
Curr Oncol Rep; 2022 Jul; 24(7):929-942. PubMed ID: 35347592
[TBL] [Abstract][Full Text] [Related]
11. Emerging biomarkers in head and neck cancer in the era of genomics.
Kang H; Kiess A; Chung CH
Nat Rev Clin Oncol; 2015 Jan; 12(1):11-26. PubMed ID: 25403939
[TBL] [Abstract][Full Text] [Related]
12. Head and neck cancer.
Mody MD; Rocco JW; Yom SS; Haddad RI; Saba NF
Lancet; 2021 Dec; 398(10318):2289-2299. PubMed ID: 34562395
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus.
Wang H; Zhao Q; Zhang Y; Zhang Q; Zheng Z; Liu S; Liu Z; Meng L; Xin Y; Jiang X
Front Immunol; 2021; 12():652054. PubMed ID: 34305889
[TBL] [Abstract][Full Text] [Related]
14. Implications of oral dysbiosis and HPV infection in head and neck cancer: from molecular and cellular mechanisms to early diagnosis and therapy.
Constantin M; Chifiriuc MC; Mihaescu G; Vrancianu CO; Dobre EG; Cristian RE; Bleotu C; Bertesteanu SV; Grigore R; Serban B; Cirstoiu C
Front Oncol; 2023; 13():1273516. PubMed ID: 38179168
[TBL] [Abstract][Full Text] [Related]
15. Head and neck cancer: Current challenges and future perspectives.
Bhat GR; Hyole RG; Li J
Adv Cancer Res; 2021; 152():67-102. PubMed ID: 34353444
[TBL] [Abstract][Full Text] [Related]
16. A Current Update on Human Papillomavirus-Associated Head and Neck Cancers.
Tumban E
Viruses; 2019 Oct; 11(10):. PubMed ID: 31600915
[TBL] [Abstract][Full Text] [Related]
17. [Advances in risk factors and genetic risk of head and neck squamous cell carcinoma].
Tu X; Ren J; Zhao Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 May; 36(5):391-396. PubMed ID: 35483694
[No Abstract] [Full Text] [Related]
18. Human papillomavirus and Epstein-Barr virus co-infection in oral and oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.
Rahman R; Shaikh MH; Gopinath D; Idris A; Johnson NW
Mol Oral Microbiol; 2023 Aug; 38(4):259-274. PubMed ID: 37014754
[TBL] [Abstract][Full Text] [Related]
19. Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites.
Blomberg M; Nielsen A; Munk C; Kjaer SK
Int J Cancer; 2011 Aug; 129(3):733-41. PubMed ID: 20878955
[TBL] [Abstract][Full Text] [Related]
20. Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes.
Chan JYK; Cheung MK; Lan L; Ng C; Lau EHL; Yeung ZWC; Wong EWY; Leung L; Qu X; Cai L; Zhu H; Boon SS; Burk RD; Chan PKS; Chen Z
Oral Oncol; 2022 Dec; 135():106245. PubMed ID: 36375420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
